Oxybutynin Tablet, Film Coated, Extended Release
Product Images NDC 50090-5353

7 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin (NDC 50090-5353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 01

F8631e88 7755 4b29 848c 7ef657463803 01
Chemical structure of oxybutynin hydrochloride, the active ingredient shown in the image, displaying its molecular arrangement including aromatic rings, ester, alkyne, and amine functional groups.*
FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 02

F8631e88 7755 4b29 848c 7ef657463803 02
A line graph depicting mean plasma R-oxybutynin concentration (ng/mL) over 24 hours. It compares two dosing regimens of oxybutynin: 10 mg once daily extended-release tablets and 5 mg taken three times daily (TID). The x-axis represents time in hours, and the y-axis shows plasma concentration levels with error bars indicated.*
FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 03

F8631e88 7755 4b29 848c 7ef657463803 03
Pharmacokinetic line graph showing mean R-oxybutynin plasma concentration (ng/mL) versus time (hours) over 24 hours after dosing. The y-axis ranges from 0.0 to 2.0 ng/mL, and data points include error bars indicating variability at each time point.*
FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 04

F8631e88 7755 4b29 848c 7ef657463803 04
A horizontal error bar chart comparing oxybutynin chloride extended-release tablets and placebo. Data points with error bars show values ranging between approximately -40 and 40 on the x-axis, labeled with the respective treatments. The chart appears to illustrate a comparison of effects or outcomes for these two groups.*
FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 05

F8631e88 7755 4b29 848c 7ef657463803 05
A horizontal error bar chart comparing 'Oxybutynin chloride extended-release tablets' and 'oxybutynin'. The x-axis ranges from -40 to 40, highlighting values around -20. The graph visually compares two data points with their associated variability.*
FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 06

F8631e88 7755 4b29 848c 7ef657463803 06
A horizontal error bar chart comparing oxybutynin chloride extended-release tablets to oxybutynin, with measured values plotted along a numerical axis ranging approximately from -40 to 40. The chart includes data points with error bars for each formulation.*
FDA Label Image

Label Image (Lbl500905353)

Label Image (Lbl500905353)
Label for oxybutynin chloride 10 mg extended-release film-coated tablets by A-S Medication Solutions. The label includes product number, lot number, storage instructions to store at 68 to 77 degrees Fahrenheit, and protection from moisture and humidity. The package contains 90 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.